GlassScriptPhysician profile
Thomas Tyree Whitfield
NPI 1073870135
$8,167.74
in general payments reported to CMS, 2019-2025
28 companies · $880 in 2025
The $880 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,056 · 2020: $889 · 2021: $809 · 2022: $2,395 · 2023: $1,143 · 2024: $996 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,019.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,356.91 | 2019-2025 | Watchman Flx, Watchman Access System, Wolverine Coronary Cutting Balloon |
| Amgen INC. | $1,344.94 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,017.76 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $681.48 | 2019-2025 | Jardiance |
| Shockwave Medical, INC | $638.86 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $540.65 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $364.80 | 2020-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $233.32 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $198.79 | 2019-2020 | |
| Philips North America LLC | $183.32 | 2022 | |
| Livanova USA, INC. | $168.62 | 2022 | |
| Altathera Pharmaceuticals LLC | $166.98 | 2023 | Sotalol Hydrochloride |
| Astrazeneca Pharmaceuticals LP | $166.71 | 2019-2022 | |
| Cardiovascular Systems INC. | $152.98 | 2019 | |
| Teleflex LLC | $127.91 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $125.07 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $114.90 | 2024 | Arcalyst |
| Penumbra, INC. | $112.12 | 2022 | |
| Ethicon US, LLC | $111.46 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $90.76 | 2022-2023 | Arcalyst |
| Novo Nordisk INC | $67.98 | 2023-2024 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $49.45 | 2025 | |
| Zoll Circulation INC | $49.11 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Terumo Medical Corporation | $27.22 | 2024-2025 | Angio-Seal, Glidesheath Slender |
| Daiichi Sankyo INC. | $25.56 | 2023 | Injectafer |
| Biohaven Pharmaceuticals, INC. | $20.07 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.28 | 2019 | |
| Chiesi USA, INC. | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Whitfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.